WO2000061806A3 - GENERIC cDNA OR PROTEIN ARRAY FOR CUSTOMIZED ASSAYS - Google Patents

GENERIC cDNA OR PROTEIN ARRAY FOR CUSTOMIZED ASSAYS Download PDF

Info

Publication number
WO2000061806A3
WO2000061806A3 PCT/US2000/008611 US0008611W WO0061806A3 WO 2000061806 A3 WO2000061806 A3 WO 2000061806A3 US 0008611 W US0008611 W US 0008611W WO 0061806 A3 WO0061806 A3 WO 0061806A3
Authority
WO
WIPO (PCT)
Prior art keywords
molecule
capture
support surface
solid support
cdna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2000/008611
Other languages
French (fr)
Other versions
WO2000061806A2 (en
Inventor
Thomas M Baer
Ann Bennett Lossing
Steven T Kunitake
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arcturus Engineering Inc
Original Assignee
Arcturus Engineering Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arcturus Engineering Inc filed Critical Arcturus Engineering Inc
Priority to EP00919976A priority Critical patent/EP1183387A2/en
Priority to AU40581/00A priority patent/AU4058100A/en
Publication of WO2000061806A2 publication Critical patent/WO2000061806A2/en
Anticipated expiration legal-status Critical
Publication of WO2000061806A3 publication Critical patent/WO2000061806A3/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

Systems and methods are described for concurrent quantification of multiple macromolecules in a flexible device. The device includes a capture location on a solid support surface. The capture location includes a capture molecule linked to the solid support surface by a first bond type. A first complexing agent including (i) a probe molecule capable of specifically binding a target molecule and (ii) a linker molecule linked by a second bond type to the probe molecule is used, such that the linker molecule can be specifically bound to the capture molecule thereby immobilizing the probe molecule on the solid support surface. The systems and methods provide advantages by allowing a user to create an array of capture locations for the concurrent quantitation of multiple macromolecules, including nucleic acids and proteins. A kit is also described, including reagents capable of linking the linker molecule to a probe molecule.
PCT/US2000/008611 1999-04-09 2000-03-31 GENERIC cDNA OR PROTEIN ARRAY FOR CUSTOMIZED ASSAYS Ceased WO2000061806A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP00919976A EP1183387A2 (en) 1999-04-09 2000-03-31 GENERIC cDNA OR PROTEIN ARRAY FOR CUSTOMIZED ASSAYS
AU40581/00A AU4058100A (en) 1999-04-09 2000-03-31 Generic cdna or protein array for customized assays

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US12857899P 1999-04-09 1999-04-09
US60/128,578 1999-04-09
US53886200A 2000-03-29 2000-03-29
US09/538,862 2000-03-29

Publications (2)

Publication Number Publication Date
WO2000061806A2 WO2000061806A2 (en) 2000-10-19
WO2000061806A3 true WO2000061806A3 (en) 2001-12-20

Family

ID=26826721

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/008611 Ceased WO2000061806A2 (en) 1999-04-09 2000-03-31 GENERIC cDNA OR PROTEIN ARRAY FOR CUSTOMIZED ASSAYS

Country Status (3)

Country Link
EP (1) EP1183387A2 (en)
AU (1) AU4058100A (en)
WO (1) WO2000061806A2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8691969B2 (en) 1994-12-12 2014-04-08 Life Technologies As Isolation of nucleic acid
US9261460B2 (en) 2002-03-12 2016-02-16 Enzo Life Sciences, Inc. Real-time nucleic acid detection processes and compositions
US9353405B2 (en) 2002-03-12 2016-05-31 Enzo Life Sciences, Inc. Optimized real time nucleic acid detection processes

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0016836D0 (en) 2000-07-07 2000-08-30 Lee Helen Improved dipstick assays (1)
US20040161741A1 (en) 2001-06-30 2004-08-19 Elazar Rabani Novel compositions and processes for analyte detection, quantification and amplification
US9777312B2 (en) 2001-06-30 2017-10-03 Enzo Life Sciences, Inc. Dual polarity analysis of nucleic acids
WO2003006657A2 (en) * 2001-07-13 2003-01-23 Custos Biotechnologie Gmbh Gene-regulatory elements for gene therapy, for the prevention and diagnosis of metastases and for the gene therapy of tumours
CA2473376A1 (en) * 2002-01-16 2003-07-31 Invitrogen Dynal As Method for isolating nucleic acids and protein from a single sample
KR100690948B1 (en) 2004-06-17 2007-03-09 한국과학기술원 Microbial surface expression method of target protein using outer membrane protein of E. coli
KR100784261B1 (en) 2006-01-02 2007-12-11 한국과학기술원 Microbial surface expression method of target protein using spore envelope membrane protein of anthrax
EP2408905B1 (en) 2009-03-16 2017-05-10 Pangu Biopharma Limited Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities
AU2010236913B2 (en) 2009-03-31 2016-03-24 Atyr Pharma, Inc. Compositions and methods comprising aspartyl-tRNA synthetases having non-canonical biological activities
AU2011248625B2 (en) 2010-04-26 2017-01-05 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-tRNA synthetase
JP6294074B2 (en) 2010-04-27 2018-03-14 エータイアー ファーマ， インコーポレイテッド Innovative discovery of therapeutic, diagnostic and antibody compositions related to protein fragments of isoleucyl-tRNA synthetase
CN103097524B (en) 2010-04-28 2016-08-03 Atyr医药公司 The innovation for the treatment of, diagnosis and the antibody compositions relevant to the protein fragments of Alanyl-tRNA synthetase finds
AU2011248457B2 (en) 2010-04-29 2017-02-16 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl tRNA synthetases
CA2797374C (en) 2010-04-29 2021-02-16 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl trna synthetases
WO2011150279A2 (en) 2010-05-27 2011-12-01 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases
WO2011135459A2 (en) 2010-04-29 2011-11-03 Medical Prognosis Institute A/S Methods and devices for predicting treatment efficacy
WO2011140135A2 (en) 2010-05-03 2011-11-10 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases
WO2011139986A2 (en) 2010-05-03 2011-11-10 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases
CA2797977C (en) 2010-05-03 2019-08-20 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-trna synthetases
CA2798139C (en) 2010-05-04 2019-09-24 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex
CN103200953B (en) 2010-05-14 2017-02-15 Atyr 医药公司 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases
CN103096914B (en) 2010-05-17 2015-08-12 Atyr医药公司 Innovative discovery of therapeutic, diagnostic and antibody compositions related to protein fragments of leucyl-tRNA synthetase
CA2800281C (en) 2010-06-01 2021-01-12 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases
AU2011289831C1 (en) 2010-07-12 2017-06-15 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
CN103108650A (en) 2010-08-25 2013-05-15 Atyr医药公司 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tyrosyl-trna synthetases
US20140106986A1 (en) 2011-06-01 2014-04-17 Medical Prognosis Institute A/S Methods and devices for prognosis of cancer relapse
IN2014MN01642A (en) 2012-02-16 2015-07-03 Atyr Pharma Inc
MX367366B (en) 2012-11-27 2019-08-16 Univ Pontificia Catolica Chile Compositions and methods for diagnosing thyroid tumors.
WO2014195032A1 (en) 2013-06-07 2014-12-11 Medical Prognosis Institute A/S Methods and devices for predicting treatment efficacy of fulvestrant in cancer patients
WO2016008048A1 (en) 2014-07-15 2016-01-21 Ontario Institute For Cancer Research Methods and devices for predicting anthracycline treatment efficacy

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2235689A (en) * 1989-09-06 1991-03-13 Ici Plc Amplification of a target nucleotide sequence
WO1993025563A1 (en) * 1992-06-17 1993-12-23 City Of Hope A method of detecting and discriminating between nucleic acid sequences
EP0698792A1 (en) * 1993-05-10 1996-02-28 Nissui Pharmaceutical Co., Ltd. Method for assaying more than one immunological ligand, and assay reagent and kit therefor
WO1997031256A2 (en) * 1996-02-09 1997-08-28 Cornell Research Foundation, Inc. Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
EP0846776A2 (en) * 1996-12-06 1998-06-10 Vysis, Inc. Devices and methods for detecting multiple analytes in samples
WO1998059243A1 (en) * 1997-06-24 1998-12-30 The Trustees Of Boston University High density streptavidin supports
WO1999015893A1 (en) * 1997-09-22 1999-04-01 Aventis Research & Technologies Gmbh & Co. Kg Addressable modular recognition system, production mode and use
WO1999032663A2 (en) * 1997-12-19 1999-07-01 Stephen Felder High throughput assay system
WO2000047767A1 (en) * 1999-02-11 2000-08-17 Astrazeneca Ab Oligonucleotide array and methods of use
WO2000058516A2 (en) * 1999-03-26 2000-10-05 Whitehead Institute For Biomedical Research Universal arrays

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2235689A (en) * 1989-09-06 1991-03-13 Ici Plc Amplification of a target nucleotide sequence
WO1993025563A1 (en) * 1992-06-17 1993-12-23 City Of Hope A method of detecting and discriminating between nucleic acid sequences
EP0698792A1 (en) * 1993-05-10 1996-02-28 Nissui Pharmaceutical Co., Ltd. Method for assaying more than one immunological ligand, and assay reagent and kit therefor
WO1997031256A2 (en) * 1996-02-09 1997-08-28 Cornell Research Foundation, Inc. Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
EP0846776A2 (en) * 1996-12-06 1998-06-10 Vysis, Inc. Devices and methods for detecting multiple analytes in samples
WO1998059243A1 (en) * 1997-06-24 1998-12-30 The Trustees Of Boston University High density streptavidin supports
WO1999015893A1 (en) * 1997-09-22 1999-04-01 Aventis Research & Technologies Gmbh & Co. Kg Addressable modular recognition system, production mode and use
WO1999032663A2 (en) * 1997-12-19 1999-07-01 Stephen Felder High throughput assay system
WO2000047767A1 (en) * 1999-02-11 2000-08-17 Astrazeneca Ab Oligonucleotide array and methods of use
WO2000058516A2 (en) * 1999-03-26 2000-10-05 Whitehead Institute For Biomedical Research Universal arrays

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NIEMEYER C M ET AL: "OLIGONUCLEOTIDE-DIRECTED SELF-ASSEMBLY OF PROTEINS: SEMISYNTHETIC DNA-STREPTAVIDIN HYBRID MOLECULES AS CONNECTORS FOR THE GENERATION OF MACROSCOPIC ARRAYS AND THE CONSTRUCTION OF SUPRAMOLECULAR BIOCONJUGATES", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 22, no. 25, 1994, pages 5530 - 5539, XP000645135, ISSN: 0305-1048 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8691969B2 (en) 1994-12-12 2014-04-08 Life Technologies As Isolation of nucleic acid
US9261460B2 (en) 2002-03-12 2016-02-16 Enzo Life Sciences, Inc. Real-time nucleic acid detection processes and compositions
US9316587B2 (en) 2002-03-12 2016-04-19 Enzo Life Sciences, Inc. Processes for quantitative or qualitative detection of single-stranded or double-stranded nucleic acids
US9353405B2 (en) 2002-03-12 2016-05-31 Enzo Life Sciences, Inc. Optimized real time nucleic acid detection processes

Also Published As

Publication number Publication date
WO2000061806A2 (en) 2000-10-19
EP1183387A2 (en) 2002-03-06
AU4058100A (en) 2000-11-14

Similar Documents

Publication Publication Date Title
WO2005050224A3 (en) Small molecule and peptide arrays and uses thereof
ATE401419T1 (en) IMMOBILIZATION OF UNMODIFIED NUCLEIC ACIDS ON SUBSTRATES ACTIVATED WITH ACYL FLUORIDE
ATE549414T1 (en) METHOD FOR ISOLATION OF CELLS
DK0787205T3 (en) Method for amplifying nucleic acids on a solid phase and reagent kits thereto
EP0915336A3 (en) Opposable-element chromatographic assay device for detection of analytes
CA2367698A1 (en) Individually addressable micro-electromagnetic unit array chips
WO2003062462A3 (en) Method for isolating nucleic acids and protein from a single sample
WO2004092342A3 (en) Lateral flow system for nucleic acid detection
CA2162568A1 (en) Method and reagent for simultaneously assaying one or more ligands in a group of preselected ligands
WO2001061043A3 (en) Parallel genotyping of multiple patient samples
WO2004005477A3 (en) Protein microarrays on mirrored surfaces for performing proteomic analyses
CA2215042A1 (en) Assay reagents and devices
WO2001094946A3 (en) Microarrays for performing proteomic analyses
GB2393512A (en) Use of a biochip for the diagnosis of sepsis or sepsis related syndrome
ATE545019T1 (en) MICROFLUIDIC EXTRACTION METHOD
WO2003091446A3 (en) Multi-functional microarrays and methods
WO2003062402A3 (en) Use of collections of binding sites for sample profiling and other applications
AU2002254892A1 (en) Sorting and immobilization system for nucleic acids using synthetic bidning systems
CA2328805A1 (en) Enzyme-protein complex
WO2001002600A3 (en) Detection of analytes using attenuated enzymes
CA2084492A1 (en) Multivalent dextran reagent for use in precipitation tests
WO2003048772A3 (en) DETECTION OF REACTIVE AUTOANTICORPS WITH ANTIGENIC MOLECULES OF PANCREATIC ISLANDS AND / OR INSULIN
WO2008094205A3 (en) A mild chemically cleavable linker system
WO2001020326A3 (en) Materials and methods for the determination of an analyte
DE59813433D1 (en) PURIFICATION OF SUBSTANCES FROM A BIOLOGICAL SAMPLE

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 2000919976

Country of ref document: EP

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWP Wipo information: published in national office

Ref document number: 2000919976

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2000919976

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP